Medgend Icon







discontinued


Calcipotriene FDA Approved Drugs

CALCIPOTRIENE [CalcipotrieneC27H40O3]
RX
-
0.005% (topical solution)
Fougera PharmsMay 6, 2008
G And W Labs IncMar 24, 2011
Glenmark PharmsJun 9, 2015
Glenmark Pharms IncMar 24, 2010
Hi Tech PharmaNov 19, 2009
TolmarMay 30, 2012
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE [Betamethasone DipropionateC28H37FO7 : Calcipotriene HydrateC27H40O3H2O]
RX
-
0.064% : 0.005% (topical ointment)
Perrigo IsraelDec 12, 2014
TolmarJan 14, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DOVONEX [CalcipotrieneC27H40O3]
RX
-
0.005% (topical cream)
Leo Pharma AsJul 22, 1996
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ENSTILAR [Betamethasone DipropionateC28H37FO7 : CalcipotrieneC27H40O3]
RX
-
0.064% : 0.005% (topical aerosol, foam)
Leo Pharma AsOct 16, 2015
  • Plaque psoriasis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SORILUX [CalcipotrieneC27H40O3]
RX
-
0.005% (topical aerosol, foam)
Mayne PharmaOct 6, 2010
  • Use of a calcipotriene containing foam for the treatment of psoriasis.
  • Use of calcipotriene foam for the topical treatment of plaque psoriasis in patients aged 18 years and older.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TACLONEX [Betamethasone DipropionateC28H37FO7 : Calcipotriene HydrateC27H40O3H2O]
RX
-
0.064% : 0.005% (topical ointment)
Leo Pharma AsJan 9, 2006
  • Psoriasis.
  • Treatment of moderate plaque psoriasis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.